Multiple sclerosis

Latest Articles

Article
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.

Neurology September 12, 2019
Editorial
Do good things come to those who wait?Dosing interval of natalizumab in MS
David B. Clifford, Kenneth L. Tyler

Neurology September 12, 2019
Case
Selective plasma exchange for multiple sclerosis with optic neuritis
Masahiro Mimori, Takeo Sato, Shusaku Omoto, et al.

Neurology: Clinical Practice September 12, 2019
Article
Lymphocyte counts and infection ratesLong-term fingolimod treatment in primary progressive MS
Edward J. Fox, Fred D. Lublin, Jerry S. Wolinsky, et al.

Neurology - Neuroimmunology Neuroinflammation September 11, 2019